Diffuse alveolar damage syndrome associated with amiodarone therapy.

Area of Science:

• Pharmacology
• Pulmonology
• Toxicology

Background:

• Amiodarone is a widely used antiarrhythmic medication with established efficacy.
• Several adverse effects are associated with amiodarone use.
• Pulmonary complications have been increasingly reported with amiodarone therapy.

Observation:

• Recent literature links amiodarone to various pulmonary disorders.
• Lung biopsy in affected patients has revealed fibrosing alveolitis.
• A case of nonspecific diffuse alveolar damage syndrome is presented in a patient treated with amiodarone.

Findings:

• Amiodarone-induced lung toxicity does not appear to be dose-dependent.
• Pulmonary complications can manifest as fibrosing alveolitis or diffuse alveolar damage.
• Cessation of amiodarone and steroid therapy are key management strategies.

Implications:

• Clinicians should be vigilant for amiodarone-induced pulmonary toxicity.
• Early recognition and intervention, including steroid use, are crucial for managing amiodarone lung injury.
• Further research into the mechanisms and management of amiodarone pulmonary toxicity is warranted.